Suppr超能文献

DNA修复基因中的遗传多态性作为霍奇金病风险的调节因素。

Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk.

作者信息

El-Zein Randa, Monroy Claudia M, Etzel Carol J, Cortes Andrea C, Xing Yun, Collier Amanda L, Strom Sara S

机构信息

Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-1439, USA.

出版信息

Cancer. 2009 Apr 15;115(8):1651-9. doi: 10.1002/cncr.24205.

Abstract

BACKGROUND

Although the pathogenesis of Hodgkin disease (HD) remains unknown, the results of epidemiologic studies suggest that heritable factors are important in terms of susceptibility. Polymorphisms in DNA repair genes may contribute to individual susceptibility for development of different cancers. However, to the authors' knowledge, few studies to date have investigated the role of such polymorphisms as risk factors for development of HD.

METHODS

The authors evaluated the relation between polymorphisms in 3 nucleotide excision repair pathway genes (XPD [Lys751Gln], XPC [Lys939Gln], and XPG [Asp1104His]), the base excision repair XRCC1 (Arg399Gln), and double-strand break repair XRCC3 (Thr241Met) in a population of 200 HD cases and 220 matched controls. Variants were investigated independently and in combination; odd ratios (OR) were calculated.

RESULTS

A positive association was found for XRCC1 gene polymorphism Arg399Gln (OR, 1.77; 95% confidence interval [95% CI], 1.16-2.71) and risk of HD. The combined analysis demonstrated that XRCC1/XRCC3 and XRCC1/XPC polymorphisms were associated with a significant increase in HD risk. XRCC1 Arg/Arg and XRCC3 Thr/Met genotypes combined were associated with an OR of 2.38 (95% CI, 1.24-4.55). The XRCC1 Arg/Gln and XRCC3 Thr/Thr, Thr/Met, and Met/Met genotypes had ORs of 1.88 (95% CI, 1.02-4.10), 1.97 (95% CI, 1.05-3.73), and 4.13 (95% CI, 1.50-11.33), respectively. XRCC1 Gln/Gln and XRCC3 Thr/Thr variant led to a significant increase in risk, with ORs of 3.00 (95% CI, 1.15-7.80). Similarly, XRCC1 Arg/Gln together with XPC Lys/Lys was found to significantly increase the risk of HD (OR, 2.14; 95% CI, 1.09-4.23).

CONCLUSIONS

These data suggest that genetic polymorphisms in DNA repair genes may modify the risk of HD, especially when interactions between the pathways are considered.

摘要

背景

尽管霍奇金淋巴瘤(HD)的发病机制尚不清楚,但流行病学研究结果表明,遗传因素在易感性方面很重要。DNA修复基因的多态性可能导致个体对不同癌症的易感性。然而,据作者所知,迄今为止很少有研究调查此类多态性作为HD发病风险因素的作用。

方法

作者评估了200例HD患者和220例匹配对照人群中3个核苷酸切除修复途径基因(XPD [Lys751Gln]、XPC [Lys939Gln]和XPG [Asp1104His])、碱基切除修复XRCC1(Arg399Gln)以及双链断裂修复XRCC3(Thr241Met)的多态性之间的关系。对各变体进行独立和联合研究;计算比值比(OR)。

结果

发现XRCC1基因多态性Arg399Gln与HD风险呈正相关(OR,1.77;95%置信区间[95%CI],1.16 - 2.71)。联合分析表明,XRCC1/XRCC3和XRCC1/XPC多态性与HD风险显著增加相关。XRCC1 Arg/Arg和XRCC3 Thr/Met基因型联合的OR为2.38(95%CI,1.24 - 4.55)。XRCC1 Arg/Gln与XRCC3 Thr/Thr、Thr/Met和Met/Met基因型的OR分别为1.88(95%CI,1.02 - 4.10)、1.97(95%CI,1.05 - 3.73)和4.13(95%CI,1.50 - 11.33)。XRCC1 Gln/Gln和XRCC3 Thr/Thr变体导致风险显著增加,OR为3.00(95%CI,1.15 - 7.80)。同样,发现XRCC1 Arg/Gln与XPC Lys/Lys共同显著增加HD风险(OR,2.14;95%CI,1.09 - 4.23)。

结论

这些数据表明,DNA修复基因的遗传多态性可能改变HD风险,尤其是在考虑各途径之间的相互作用时。

相似文献

引用本文的文献

本文引用的文献

7
A risk model for prediction of lung cancer.一种用于预测肺癌的风险模型。
J Natl Cancer Inst. 2007 May 2;99(9):715-26. doi: 10.1093/jnci/djk153.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验